Login

Join Now

Utah Life Sciences News & Events

Canary Speech And CareLink360 Partner To Support Family Caregivers And The Aging Adults They Care For

April 11, 2024

Canary Speech and CareLink360 Form Partnership to Support Family Caregivers and the Aging Adults They Care For.

Flemington, NJ – April 8, 2024 – Today we are excited to announce a new partnership between Canary Speech, an AI-driven vocal biomarker health company and CareLink360, a digital health, AgeTech, and data analytics insights company, to support family caregivers and the aging adults under their care.

The partnership is introducing an innovative and groundbreaking integrated digital health solution designed to combat the pervasive issues of caregiver burnout, stress, isolation, and loneliness on a global scale.

With the rapidly growing aging adult population, the role of the family caregiver is and will continue to become an essential part of understanding and managing the total cost of care. The partnership between Canary Speech and CareLink360 will be critical in utilizing the efficacy of voice biomarkers to identify early signs of anxiety, depression, stress, and cognitive changes in family caregivers enrolled in Medicaid, Medicare, DSNP, or other health plans.

Moreover, this partnership and combined ecosystem solution will provide early intervention resources for family caregivers experiencing mental health challenges. By equipping the individuals under their care with the CareLink360 Digital Health Companion™ for remote monitoring, health education, cognitive and behavioral support applications, and real-time leading indicators of health reports, family caregivers will have invaluable tools to collaborate with healthcare professionals and the extended care team.

“We are thrilled to be integrating our pioneering AI voice biomarker technology with CareLink360’s ecosystem to support family caregivers. We see our partnership with CareLink360 as instrumental in investing in family caregiver health as a step toward a more supportive and effective healthcare ecosystem, with broad benefits for all stakeholders,” explains Henry O’Connell, CEO and Co-founder of Canary Speech.

David S. Duplay, Chairman & CEO of CareLink360 says, the Canary Speech state-of-the-art AI vocal biomarker platform utilizes advanced AI algorithms to analyze subtle changes in voice patterns and monitor cognitive function changes. Combined with CareLink360’s Digital Health Companion, this non-invasive, efficient method offers a revolutionary approach to tracking the progression of family caregiver mental wellbeing and the effectiveness of treatments.”

Together, the Canary Speech – CareLink360 partnership will elevate patient care standards, alleviate family caregiver burdens, improve healthcare efficiencies while mitigating healthcare costs. This will provide substantial benefits to insurers, healthcare providers, and all stakeholders within the healthcare delivery system.

About CareLink360

At CareLink360, our mission is Change The Way The World Ages by being the global leader in assisting our clients to deliver high-quality, person-and-patient centered care across the care continuum; through our integrated, patented, and easy to use Digital Health Companion. We strive to mitigate the global epidemic of isolation and loneliness which affects people of all ages, races, gender, and socioeconomic backgrounds. The current competitive landscape consists of browser and web-based applications which require a base knowledge of user technology. The CareLink360 Digital Health Companion™ and ecosystem is currently the single device in the market that was designed from the ground up to accommodate non-technical users and is protected under three US patents.

Visit www.MyCareLink360.com.

About Canary Speech

Canary Speech is the global leader in the speech digital biomarker industry by achieving real time vocal analysis on as little as 40 seconds of speech using smart devices. Canary Speech is seeking to advance speech and language applications for the hospital, health and wellness, and pharmaceutical markets. The Utah-based company enhances patient care and outcomes by improving access to care, quality of care and management of health conditions with its patented AI speech technology. Canary Speech technology also provides the opportunity to enhance telemedicine and remote medical services.

For more information, visit www.canaryspeech.com